Petitioner Cites Cox In Reply Brief In High Court ‘Skinny Label’ Patent Row
WASHINGTON, D.C. — A petitioner bioequivalent pharmaceutical maker that is arguing to the U.S. Supreme Court that a patent holder’s complaint failed to state a claim for induced infringement because the...To view the full article, register now.
Already a subscriber? Click here to view full article